Description: Solarvest BioEnergy Inc. is a Canada-based algae technology company, which is engaged in the development of specially selected algal-based production systems to produce natural-based green commercial products, such as nutritional products, oils and biologic therapies, among others. The Company is focused on developing algae strains that are rich in Docosahexaenoic Acid/ Eicosapentaenoic Acid (DHA/EPA), which are a form of Omega 3 fatty acids used by the food enhancement and Nutraceutical markets. It is also focuses on developing algae strains that can be used to produce proteins with the first such target being a therapeutic that has use in human and animal orthopedic surgery and genetically modified algae strain that can be used to produce hydrogen. It is also focused on custom producing organic chemical-free Omega 3s and other nutritional oils. Its subsidiaries include Phycobiologics (Europe) Limited, Phyco Hydrogen Inc. and Solarvest (P.E.I.) Inc.
Home Page: www.solarvest.ca
SVS Technical Analysis
439 Helmcken Street
Vancouver,
BC
V6B 2E6
Canada
Phone:
674 204 4095
Officers
| Name | Title |
|---|---|
| Mr. Gerri J. Greenham | Pres |
| Mr. Gerard Watts | Interim Chief Financial Officer |
| Mr. Garth Greenham | Chief Operating Officer |
| Mr. Claes Ellegaard | CEO & Additional Director |
| Mr. Richard T. Groome BA | Chairman of Financial Advisory Committee |
Exchange: V
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 24.5012 |
| Price-to-Sales TTM: | 4854.0703 |
| IPO Date: | |
| Fiscal Year End: | July |
| Full Time Employees: | 0 |